Ariadna Roqué

421 total citations
4 papers, 9 citations indexed

About

Ariadna Roqué is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ariadna Roqué has authored 4 papers receiving a total of 9 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Infectious Diseases and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Ariadna Roqué's work include Cancer, Lipids, and Metabolism (1 paper), Advanced Breast Cancer Therapies (1 paper) and Cancer-related Molecular Pathways (1 paper). Ariadna Roqué is often cited by papers focused on Cancer, Lipids, and Metabolism (1 paper), Advanced Breast Cancer Therapies (1 paper) and Cancer-related Molecular Pathways (1 paper). Ariadna Roqué collaborates with scholars based in Spain. Ariadna Roqué's co-authors include Joan Brunet, Elisabet Cuyàs, Bárbara Adamo, Ariadna Giró‐Perafita, A Caballero, Gemma Viñas, A. Fernandez Ortega, Mireia Melé, Sofía González‐Ortiz and A. Rodríguez and has published in prestigious journals such as Annals of Oncology, Pharmaceuticals and ESMO Open.

In The Last Decade

Ariadna Roqué

4 papers receiving 9 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariadna Roqué Spain	3	4	4	2	2	2	4	9
Choushi Wang China	2	4 1.0×	4 1.0×	1 0.5×		2 1.0×	2	13
Gloria Petersen United States	2	5 1.3×	3 0.8×	3 1.5×	2 1.0×	1 0.5×	5	9
Hannes Jürgens Estonia	2	3 0.8×	3 0.8×			2 1.0×	2	3
Érica Mendonça Portugal	1	5 1.3×	4 1.0×	1 0.5×	2 1.0×		2	6
Qin Wenwen China	2	3 0.8×	4 1.0×			2 1.0×	4	10
Daniel Kejzman Israel	2	3 0.8×	3 0.8×			1 0.5×	2	3
Julie M. Gastier-Foster United States	2	7 1.8×	6 1.5×			2 1.0×	3	11
Suzanne L. Meinig United States	2	3 0.8×	4 1.0×	1 0.5×			2	6
Danya Cheeseman United Kingdom	2	5 1.3×	3 0.8×			1 0.5×	2	7

Countries citing papers authored by Ariadna Roqué

Since Specialization

Citations

This map shows the geographic impact of Ariadna Roqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariadna Roqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariadna Roqué more than expected).

Fields of papers citing papers by Ariadna Roqué

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariadna Roqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariadna Roqué. The network helps show where Ariadna Roqué may publish in the future.

Co-authorship network of co-authors of Ariadna Roqué

This figure shows the co-authorship network connecting the top 25 collaborators of Ariadna Roqué. A scholar is included among the top collaborators of Ariadna Roqué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariadna Roqué. Ariadna Roqué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Rodríguez, A., Ariadna Roqué, A. Fernandez Ortega, et al.. (2025). 270P First-line cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in patients with a homologous recombination repair (HRR) germline pathogenic variant (PV) and breast cancer (BC): Clinical outcomes and mechanisms of resistance. ESMO Open. 10. 104825–104825. 1 indexed citations

2.

Bosch‐Barrera, Joaquim, Ariadna Roqué, M. Carmen Carmona-García, et al.. (2021). Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. Pharmaceuticals. 15(1). 19–19. 4 indexed citations

3.

Viñas, Gemma, Glòria Oliveras, Ariadna Giró‐Perafita, et al.. (2014). Triple Negative Breast Cancer: Clinicopathologic Characteristics and Fatty Acid Synthase (Fasn) Expression As a Potential Target. Annals of Oncology. 25. iv60–iv60. 2 indexed citations

4.

Webb, Susan M., Ariadna Roqué, A Caballero, et al.. (1999). Riesgo aterogénico en la deficiencia de hormona de crecimiento del adulto. Acceda (Universidad de Las Palmas de Gran Canaria). 46(10). 322. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact